Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Sotera Health Company
SHC
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $5.1B
$17.93
▲ +1.01%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$10.94 - $19.85
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 52.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Above-average volatility (beta 1.8).
Growth
Strong growth ahead
Value
Fairly valued vs sector peers
Momentum
Strong
+18.6% over 3m
Quality
Strong
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying SHC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 6, 2026
MAY 5, 2026
Reported EPS of $0.18 vs $0.17 consensus (+5.9% surprise). Revenue of $280.0M vs $270.8M expected (+3.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+5.9%
Next: Aug 6, 2026
Revenue trend · last 1Q
—
Q1 26
$280.0M
Margins · last 1Q
Profit
9.5%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$18.00
▲ +0.4% vs $17.93
Latest: Barclays · Jun 24, 2026
1 analyst covering
vs Industry
How SHC stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related
Peers & themes
Peers
No peer data available.
Themes
No themes assigned.